GLP-1 side effects should be discussed with a doctor when nausea, constipation, vomiting, reflux, fatigue, dizziness, abdominal pain, dehydration, or poor intake interferes with daily life, prevents the patient from eating enough protein or drinking enough fluid, worsens after a dose increase, persists for more than a short adjustment period, or feels severe or unusual
Thursday at 7am one week
Initially, the industry may have overlooked this trend, but as these convenient, health-marketed drinks began capturing a substantial market share, it became a critical issue
However, specific cancer screening beyond standard age-appropriate programmes (such as bowel, breast, and cervical screening) is not required solely because you are taking a GLP-1 medicine
According to Cullaro et al., in their complete review of national registry data, there was a 187% increase in the proportion of patients with cirrhosis and CKD at the time of liver transplant between 2002 and 2017. Furthermore, they reported, CKD at transplant was associated with a 16% independent higher risk of mortality post-liver transplant after adjusting for factors such as recipient age, etiology of cirrhosis, ethnicity, hepatic encephalopathy, era of transplant, diabetes mellitus, and donor risk index. This demonstrates the rising prevalence of CKD and its detrimental effects on patients undergoing liver transplantation
Adv Sci 12(4)
